论文部分内容阅读
巨大的市场潜力和日益激烈的国际竞争,我国医药产业处于较为尴尬的境地。随着专利制度的不断发展,可仿制的药品将越来越少,自主创新能力已成为决定整个行业命运的命门。医药制造行业是典型的技术型行业,唯有开发创新产品和特色产品才能在市场竞争中立于不败之地。作为中国最大的民营医药企业之一的复星医药集团一直强调自主创新,那么,复星医药将如何作为?我们采访了复星医药集团总裁汪群斌。
Huge market potential and increasingly fierce international competition, China’s pharmaceutical industry is in a more awkward position. With the continuous development of the patent system, there will be fewer and fewer generic medicines and the ability of independent innovation has become the lifeblood of the entire industry. The pharmaceutical manufacturing industry is a typical technology-based industry. Only by developing innovative products and distinctive products can they be invincible in market competition. As Fosun Pharma, one of the largest private pharmaceutical companies in China, has always emphasized independent innovation, how will Fosun Pharma act? We interviewed Wang Qunbin, president of Fosun Pharma.